Malaria in infants publications
-
Defining and validating a measure of parasite resistance to sulfadoxinepyrimethamine (SP) that would be indicative of the protective efficacy of SP for intermittent preventive treatment in infancy (SP-IPTi)
Report of the technical consultation, Geneva, September 10-11, 2009 - Intermittent preventive treatment for infants using sulfadoxine-pyrimethamine (SP-IPTi) for malaria control in Africa : implementation field guide
-
Iron supplementation of young children in regions where malaria transmission is intense and infectious disease highly prevalent
WHO Statement, January 2006 - Reducing the burden of anemia in infants and young children in malaria-endemic countries of Africa: from evidence to action
-
Report of the technical consultation on intermittent preventive treatment in infants (IPTi)
Technical Expert Group on Preventive Chemotherapy, Geneva, April 2009 -
Report of the Technical Expert Group (TEG)
Geneva, 8–10 October 2007 -
WHO Policy recommendation on Intermittent Preventive Treatment during infancy with sulphadoxine-pyrimethamine (SP-IPTi) for Plasmodium falciparum malaria control in Africa
March 2010